The Emory Institute for Drug Development (EIDD) was founded in 2009 to discover therapeutic agents to treat infectious diseases, particularly viral diseases. The EIDD has the personnel, laboratory space and equipment necessary to conduct the key preclinical activities required to bring a drug into clinical development. DRIVE , the �industrial partner� of the EIDD, is organized as a virtual drug development company with a highly experienced management team. As a 501(c) (3) entity, it will be able to in-license attractive development opportunities from Emory or elsewhere on commercially favorable terms. Then, either by using its own seed capital or by raising external funds, it can utilize the EIDD and/or external vendors to move these opportunities quickly and efficiently down the development continuum to meet the critical need for new therapeutic agents to treat emerging infectious disease.  DRIVE has been designed to be a self-sustaining entity, i.e., the company can reinvest its earnings from outlicensing or sale of assets in new development opportunities as they emerge.

DRIVE: An innovative, nonprofit drug discovery company

246th National Meeting (2013)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.